Oventus CEO and founder, Dr Chris Hart recently presented at the NWR’s Virtual Health Conference, providing an update to investors on Oventus’ progress and discussing our strategic response to COVID-19.
During the presentation, Dr Hart discusses:
- An overview of Obstructive Sleep Apnoea (OSA);
- What is driving adoption of Oventus’ Lab in Lab Model;
- Oventus’ strategic response to COVID-19, which includes use of telehealth and other remote procedures;
- How Oventus and its sleep partners are helping frontline workers in Canada suffering with OSA during the current pandemic; and
- The U.S. home-care model, which is in the late stages of development and expected to be rolled out in the U.S. shortly.
Any investors interested in a direct update are invited to contact Jane Lowe via firstname.lastname@example.org or +61 411 117 774.
Leave a Reply